GSK CEO Sir Andrew Witty Interviewed on Q2 2012 Results
LONDON, July 25, 2012 /PRNewswire/ –
Pharmaceutical group GlaxoSmithKline concedes pricing pressure in Europe had affected
overall performance in the second quarter but says the Group was making “good progress”
against its strategic agenda.
In a video interview, CEO Sir Andrew Witty said he had seen strong performances in the
Emerging Markets, Japan and the group’s Consumer business. Looking forward he said he now
expected full-year 2012 to be in line with 2011 as the headwinds in Europe act as a brake
The Pharma boss also noted the company’s late stage pipeline was the strongest it has
been for over a decade and that gave him confidence for the mid to longer term performance
of the Group.
“The evidence of Q2 is we are making good progress and we have to stay focused on
getting those projects to successful conclusion.”
The interview and transcript are available now on
MerchantCantos produces in-depth interviews, documentaries and webcasts with senior
company executives. If you would like to contact us, please email
email@example.com or phone +44-207-936-1352.